C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/495 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) C07D 471/14 (2006.01) C07D 487/14 (2006.01) C07D 491/147 (2006.01) C07D 495/14 (2006.01) C07F 9/6561 (2006.01)
Patent
CA 2210631
Tricyclic compound of general formula (I) as defined herein which exhibit antagonist activity at V1 and/or V2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and process for preparing such compounds.
L'invention porte sur des composés tricycliques de formule générale (I) présentant une activité antogoniste vis-à-vis des récepteurs V1 et/ou V2 et une activité in vivo antagoniste de la vasopressine, sur des procédés d'utilisation de ces composés dans le traitement de maladies caractérisées par un excès de réabsorption rénale d'eau et un procédé de préparation desdits composés.
Albright Jay Donald
Dusza John Paul
Sum Fuk-Wah
Venkatesan Aranapakm Mudumbai
American Cyanamid Company
Ridout & Maybee Llp
Wyeth Holdings Corporation
LandOfFree
Tricyclic benzazepine vasopressin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic benzazepine vasopressin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic benzazepine vasopressin antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732762